Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections
European Journal of Nuclear Medicine and Molecular Imaging · 2023
DOI: 10.1007/s00259-023-06141-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Feredun Azari und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Foundation for the National Institutes of Health, Thoracic Surgery Foundation.
Abstract (Originalsprache)
PURPOSE: Pafolacianine, a folate receptor alpha-targeted NIR tracer, has demonstrated clear efficacy in intraoperative molecular imaging-guided (IMI) lung cancer surgery. However, the selection of patients who would benefit from IMI remains challenging given the variability of fluorescence with patient-associated and histopathologic factors. Our goal in this study was to prospectively evaluate whether preoperative FRα/FRβ staining can predict pafolacianine-based fluorescence during real-time lung cancer resections. METHODS: This was a prospective study conducted between 2018 and 2022 that reviewed core biopsy and intraoperative data from patients with suspected lung cancer. A total of 196 patients were deemed eligible, of whom core biopsies were taken from 38 patients and assessed for FRα and FRβ expression by immunohistochemistry (IHC). All patients underwent infusion of pafolacianine 24 h prior to surgery. Intraoperative fluorescence images were captured with the VisionSense bandpass filter-enabled camera. All histopathologic assessments were performed by a board-certified thoracic pathologist. RESULTS: Of the 38 patients, 5 (13.1%) were found to have benign lesions (necrotizing granulomatous inflammation, lymphoid aggregates) and 1 had metastatic non-lung nodule. Thirty (81.5%) had malignant lesions, with the vast majority (23, 77.4%) being lung adenocarcinoma (7 (22.5%) SCC). None of the benign tumors (0/5, 0%) exhibited in vivo fluorescence (mean TBR of 1.72), while 95% of the malignant tumors fluoresced (mean TBR of 3.11 ± 0.31) compared to squamous cell carcinoma (1.89 ± 0.29) of the lung and sarcomatous lung metastasis (2.32 ± 0.09) (p < 0.01). The TBR was significantly higher in the malignant tumors (p = 0.009). The median FRα and FRβ staining intensities were both 1.5 for benign tumors, while the FRα and FRβ staining intensities were 3 and 2 for malignant tumors, respectively. Increased FRα expression was significantly associated with the presence of fluorescence (p = 0.01), CONCLUSION: This prospective study sought to determine whether preoperative FRα and FRβ expression on core biopsy IHC correlates with intraoperative fluorescence during pafolacianine-guided surgery. These results, although of small sample size, including limited non-adenocarcinoma cohort, suggest that performing FRα IHC on preoperative core biopsies of adenocarcinomas as compared to squamous cell carcinomas could provide low-cost, clinically useful information for optimal patient selection which should be further explored in advanced clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
- University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Ohio State University School of Medicine, Ohio, Columbus, USA.
- Ankara Yildirim Beyazit Faculty of Medicine, Ankara, Turkey.
- Faculty of Medicine, Ankara University, Ankara, Turkey.
- Faculty of Medicine, Ege University, Izimir, Turkey.
ORCID-Profile: Feredun Azari
Förderung
- NCI NIH HHS
- Foundation for the National Institutes of Health
- Thoracic Surgery Foundation
Zitieren
APA
Azari, F., Zhang, K., Kennedy, G., Bou-Samra, P., Chang, A., Nadeem, B., Chang, A., Galandarova, A., Ibrahimli, A., Karimov, Z., Din, A., Kucharczuk, J., Doraid, J., Pechet, T., Delikatny, E., & Singhal, S. (2023). Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06141-3
Vancouver
Azari F, Zhang K, Kennedy G, Bou-Samra P, Chang A, Nadeem B, et al. Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06141-3
BibTeX
@article{Azari2023,
author = {Azari, Feredun and Zhang, Kevin and Kennedy, Gregory and Bou-Samra, Patrick and Chang, Ashley and Nadeem, Bilal and Chang, Austin and Galandarova, Aysuna and Ibrahimli, Arturan and Karimov, Ziya and Din, Azra and Kucharczuk, John and Doraid, Jarrar and Pechet, Taine and Delikatny, Edward and Singhal, Sunil},
title = {Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2023},
doi = {10.1007/s00259-023-06141-3}
}
EUVIMED